Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart

July 13, 2021


Rapid Dose Therapeutics-Branded Cannabis Products in Retail Locations Across Canada Via Master Distribution Agreement with Namaste Technologies Subsidiary CannMart Rapid Dose Therapeutics Announces its Latest Innovation with the Launch of QuickSips™ Biodegradable Infused Straw BURLINGTON, Ontario – July 13, 2021- Rapid Dose Therapeutics Corp. (“RDT”...

Rapid Dose Granted Management Cease Trade Order

June 29, 2021


Rapid Dose Granted Management Cease Trade Order TORONTO, ONTARIO, June 29, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) announces that, further to its news release dated June 18, 2021, the Company’s principal regulator, the Ontario Securities Commission (the “OSC”) granted a management...

Rapid Dose Therapeutics and McMaster University Provide Update on COVID-19 Vaccine Research Collaboration with Orally Dissolvable QuickStrip™ Technology

June 23, 2021


The National Research Council of Canada provides the SARS-CoV-2 spike protein for the next phase of preclinical studies BURLINGTON, Ontario – June 23, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are pleased to announce that they have...

Rapid Dose Therapeutics Signs Exclusive Manufacturing And Distribution Agreement With Maplex Naturals Inc.

April 13, 2021


BURLINGTON, Ontario – April 13, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...

Rapid Dose Therapeutics Closes Purchase and Amalgamation of Consolidated Craft Brands

March 19, 2021


BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an...

Rapid Dose Therapeutics Signs Production Agreement with OG Laboratories to Produce Cannabis Vape and CBD from Hemp Products

March 10, 2021


BURLINGTON, Ontario, March 10, 2021 (GLOBE NEWSWIRE) — Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is a Canadian Life Science company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film, infused with an active...

Rapid Dose Therapeutics Completes Amalgamation Of Consolidated Craft Brands

March 8, 2021


BURLINGTON, Ontario March 8, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions. The flagship product ‘QuickStrip™’ is a thin, orally dissolvable film infused with an active...

Rapid Dose Therapeutics Executes Letter of Intent to Acquire Consolidated Craft Brands

January 11, 2021


BURLINGTON, Ontario January 11, 2021 – Rapid Dose Therapeutics Corp. “RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce that it has entered into a binding Letter of Intent “LOI”)...

Rapid Dose Therapeutics Delivers Shipments of Oral Strips to Thrive Cannabis, in Stores Now

December 21, 2020


BURLINGTON, Ontario December 21, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, has worked diligently with its customer, Thrive Cannabis Inc. (“Thrive”), this past year preparing to...

Rapid Dose Therapeutics Closes First Tranche of Non-Brokered Private Placement

December 15, 2020


BURLINGTON, Ontario – December 15, 2020 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce the closing of the first tranche of a Non-Brokered Private...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16